Enhancing the Bioavailability of Resveratrol: Combine It, Derivatize It, or Encapsulate It?
Article in Pharmaceutics (April 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Resveratrol-Based Liposomes Improve Cardiac Remodeling Induced by Isoproterenol Partially by Modulating MEF2, Cytochrome C and S100A1 Expression
Article in Dose-Response (April 2024)
Implication of MAPK, Lipocalin-2, and Fas in the protective action of liposomal resveratrol against isoproterenol-induced kidney injury
Article in Saudi Pharmaceutical Journal (December 2023)